基因工程在干细胞和体细胞中的方法用于生成产生胰岛素的β细胞
Abiramy Jeyagaran1, Katja Schenke-Layland2
1Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Eberhard Karls University Tübingen, Germany.
Advanced drug delivery reviews
|December 22, 2025
概括
针对1型糖尿病的细胞替代疗法面临细胞可用性挑战. 本综述探讨了使用关键转录因子 (NGN3,PDX1,MAFA) 来产生从干细胞中治疗性β细胞的转化差异化.
科学领域:
- 干细胞生物学 干细胞生物学
- 内分泌学 在内分泌学.
- 再生医学是一种再生医学.
背景情况:
- 细胞替代疗法对1型糖尿病具有前景.
- 可移植β细胞的有限可用性阻碍了治疗.
- 需要采用替代策略来产生治疗性β细胞.
研究的目的:
- 通过转差异化审查贝塔细胞生成方面的进展.
- 讨论转录因子NGN3,PDX1和MAFA在β细胞成熟中的作用.
- 探索关于细胞发育和可塑性的见解.
主要方法:
- 关于转差异化方法的最新文献的综述.
- 专注于使用神经新生素3 (NGN3),胰腺/双胞胎母体盒蛋白1 (PDX1) 和MAF BZIP转录因子A (MAFA) 的使用.
- 分析它们在产生可感应葡萄糖,分泌胰岛素的β细胞中的作用.
主要成果:
- 转录因子NGN3,PDX1和MAFA对于成年β细胞功能至关重要.
- 转差异化为产生治疗性β细胞提供了一个可行的替代方案.
- 了解这些因素可以了解细胞的可塑性和发育.
结论:
- 使用NGN3,PDX1和MAFA进行转差是治疗1型糖尿病的一个有前途的策略.
- 对这些转录因子的进一步研究可以促进β细胞的产生.
- 这种方法增强了细胞替代疗法的潜力.
相关概念视频
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Somatic to iPS Cell Reprogramming
2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
What is Genetic Engineering?
79.5K
Overview
79.5K


